NCT04037046

Brief Summary

The main purpose of the study is to compare the acceptance and viability of three strategies aimed to screen hepatitis C virus (HCV) infection in a birth cohort by: a) invitation letter offering HCV screening with dried blood spot (DBS) testing at the primary care center, b) invitation letter offering both HCV and colorectal cancer (CCR) screening with faecal occult test (FOT) at the primary care center, and c) invitation letter offering self-collected screening at home for HCV and CCR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
609

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 30, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

April 30, 2021

Status Verified

April 1, 2021

Enrollment Period

8 months

First QC Date

July 23, 2019

Last Update Submit

April 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Acceptance of the interventions

    overall screening rate (number of subjects participating after enrollment)

    12 months

Secondary Outcomes (3)

  • Feasibility of the intervention measuring quality of spotted cards

    12 months

  • Subject characteristics associated with participation and feasibility of the different strategies

    12 months

  • Effectiveness of each strategy: rate of HCV positivity

    12 months

Study Arms (3)

Screening HCV with DBS at primary care centers

EXPERIMENTAL

Patients assigned to the strategy 1 will receive an invitation letter for HCV screening with DBS at the primary care center to be performed by the general practitioner

Behavioral: Screening HCV at primary care center

Screening HCV and CCR with FOT at primary care centers

ACTIVE COMPARATOR

Patients assigned to the strategy 2 will receive an invitation letter for HCV screening with DBS and CCR screening with FOT at the primary care center to be performed by the general practitioner

Behavioral: Screening HCV attached onto CCR screening

Self-testing at home for screening HCV and CCR

ACTIVE COMPARATOR

Patients assigned to the strategy 3 will receive an invitation letter for self-testing at home for HCV screening with DBS, and CCR screening with FOT

Behavioral: Screening HCV attached onto CCR screening by self-testing

Interventions

Patients assigned to this strategy will receive an invitation letter for HCV screening with DBS and CCR screening with FOT at the primary care center to be performed by the general practitioner

Screening HCV and CCR with FOT at primary care centers

Patients assigned to this strategy will receive an invitation letter for self-testing for HCV screening with DBS, and CCR screening with FOT

Self-testing at home for screening HCV and CCR

DBS for HCV screening at primary care center

Screening HCV with DBS at primary care centers

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 50-70 years
  • Subjects attending selected primary care centers
  • Willing to participate (informed consent signed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manuel Hernandez-Guerra, MD

San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain

Location

Related Publications (3)

  • Buti M, Dominguez-Hernandez R, Casado MA, Sabater E, Esteban R. Healthcare value of implementing hepatitis C screening in the adult general population in Spain. PLoS One. 2018 Nov 28;13(11):e0208036. doi: 10.1371/journal.pone.0208036. eCollection 2018.

    PMID: 30485377BACKGROUND
  • Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, Prins M. Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health. 2014 Jan 22;14:66. doi: 10.1186/1471-2458-14-66.

    PMID: 24450797BACKGROUND
  • Tuaillon E, Mondain AM, Meroueh F, Ottomani L, Picot MC, Nagot N, Van de Perre P, Ducos J. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology. 2010 Mar;51(3):752-8. doi: 10.1002/hep.23407.

    PMID: 20043287BACKGROUND

MeSH Terms

Conditions

Hepatitis C

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System Diseases

Study Officials

  • Manuel Hernandez-Guerra, MD

    MD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 23, 2019

First Posted

July 30, 2019

Study Start

March 1, 2019

Primary Completion

November 1, 2019

Study Completion

November 1, 2019

Last Updated

April 30, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations